Philips Takes Minority Stake in BG Medicine Under R&D Alliance | GenomeWeb

NEW YORK (GenomeWeb News) – Royal Philips Electronics and BG Medicine said last week that they have formed an alliance to develop next-generation molecular healthcare products for use in areas including molecular imaging and point-of-care diagnostics.

As part of the deal, Philips has acquired an undisclosed minority stake in privately held BG.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.